stockportfolio.pro
Stocks / CORZ vs MANH
CORZ vs MANH
Core Scientific, Inc. and Manhattan Associates, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Technology.
| Core Scientific, Inc. (CORZ) | Manhattan Associates, Inc. (MANH) | |
|---|---|---|
| Market cap | $8.4B | $8.6B |
| Revenue (latest FY) | $319.02M | $1.08B |
| Net income (latest FY) | $-288.62M | $219.95M |
| Revenue growth (5y CAGR) | 39.5% | 13.0% |
| Net margin | -90.5% | 20.3% |
| Return on equity | 30.0% | 69.9% |
| P/E ratio | — | 40.7 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 10 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CORZ — free Open MANH — freeFrequently asked questions
Which is bigger, CORZ or MANH?
Manhattan Associates, Inc. is larger by market capitalization — $8.6B versus $8.4B.
Which grows faster, CORZ or MANH?
Over the last five fiscal years, Core Scientific, Inc. grew revenue faster — 39.5%/yr versus 13.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.